While our results and the work by Weinhoffer et al. focused on CALD, the use of NfL has been previously demonstrated in a wide variety of conditions, including amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and most recently in COVID-19 infection [18,25,26]. Here, NEFL is linked to myeloid sarcoma.